![]() |
產(chǎn)地 | 進(jìn)口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS11325 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-SMYD2 |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human SMYD2 |
產(chǎn)品訂購信息:
英文名稱 Anti-SMYD2
中文名稱 組蛋白甲基轉(zhuǎn)移酶SMYD2抗體費(fèi)用
別 名 HSKM B; HSKM-B; HSKMB; Histone methyltransferase SMYD2; HSKM-B; Lysine N-methyltransferase 3C; MGC119305; N lysine methyltransferase SMYD2; N-lysine methyltransferase SMYD2; SET and MYND domain containing 2; SET and MYND domain containing protein 2; SET and MYND domain-containing protein 2; Smyd2; SMYD2_HUMAN; Zinc finger MYND domain containing 14; ZMYND14.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 染色質(zhì)和核信號(hào) 信號(hào)轉(zhuǎn)導(dǎo) 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 50kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human SMYD2
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
組蛋白甲基轉(zhuǎn)移酶SMYD2抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Protein-lysine N-methyltransferase that methylates both histones and non-histone proteins. Specifically methylates histone H3 'Lys-4' (H3K4me) and dimethylates histone H3 'Lys-36' (H3K36me2). Has also methyltransferase activity toward non-histone proteins such as p53/TP53 and RB1. Monomethylates 'Lys-370' of p53/TP53, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity of p53/TP53. Monomethylates 'Lys-860' of RB1/RB.
Function : Protein-lysine N-methyltransferase that methylates both histones and non-histone proteins. Specifically methylates histone H3 'Lys-4' (H3K4me) and dimethylates histone H3 'Lys-36' (H3K36me2). Has also methyltransferase activity toward non-histone proteins such as p53/TP53 and RB1. Monomethylates 'Lys-370' of p53/TP53, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity of p53/TP53. Monomethylates 'Lys-860' of RB1/RB.
Subunit : Interacts with RNA polymerase II and HELZ. Interacts with SIN3A and HDAC1 (By similarity). Interacts (via MYND-type zinc finger) with EPB41L3. Interacts (via SET domain) with p53/TP53. Interacts with RB1 and HSP90AA1.
Subcellular Location : Cytoplasm, cytosol (By similarity). Nucleus (By similarity).
Similarity : Contains 1 MYND-type zinc finger.
Contains 1 SET domain.
Database links : UniProtKB/Swiss-Prot: Q9NRG4.2
Anti-OVA/HRP 辣根過氧化物酶標(biāo)記兔抗雞卵白蛋白抗體IgGMulti-class antibodies規(guī)格: 0.2ml
PACAP-38 腺苷酸環(huán)化酶激活肽-38(抗原)Multi-class antibodies規(guī)格: 0.5mg
胸腺肽 α-1抗體 Anti-Thymosin α-1 0.1ml
S100 alpha 2 英文名稱: S100A2抗體 0.2ml
EAAT3 英文名稱: 膠質(zhì)細(xì)胞谷酸運(yùn)載蛋白3抗體(神經(jīng)/上皮細(xì)胞谷酸運(yùn)載蛋白) 0.1ml
Rhesus antibody Rh Phospho-KSR1 (Ser392) 磷酸化Ras信號(hào)轉(zhuǎn)導(dǎo)KSR1蛋白抗體 規(guī)格 0.1ml
PACAP-38 腺苷酸環(huán)化酶激活肽-38(抗原)Multi-class antibodies規(guī)格: 0.5mg
Anti-PRDX3/FITC 熒光素標(biāo)記過氧化還原酶3抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rabbit Anti-horse IgG Whole serum 兔抗馬IgG抗血清Multi-class antibodies規(guī)格: 1ml
擬南芥IKI3抗體 Anti-IKI3 family protein 0.2ml
Donkey anti-Gpig IgG whole serum 驢抗豚鼠IgG抗血清 1ml
FAKD3 英文名稱: 下頜綜合征相關(guān)蛋白FAKD3抗體 0.2ml
Rhesus antibody Rh phospho-PTPN7(Ser93) 磷酸化非受體型蛋白酪氨酸磷酸酶7抗體 規(guī)格 0.1ml
Rabbit Anti-horse IgG Whole serum 兔抗馬IgG抗血清Multi-class antibodies規(guī)格: 1ml
phospho-NFKB p65 (pSer536) peptide 磷酸化細(xì)胞核因子/磷酸化k基因結(jié)合核因子抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-APOD 載脂蛋白D抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-ATXN1(Thr236) 磷酸化失調(diào)癥蛋白1抗體 規(guī)格 0.1ml
山羊抗兔 IgG(H+L)/Biotin 0.1ml 美國Jackson公司分裝
VEGF-A 英文名稱: 內(nèi)皮生長因子A 0.1ml
DNA polymerase delta 英文名稱: DNA聚合酶γ抗體 0.2ml
Anti-APOD 載脂蛋白D抗體Multi-class antibodies規(guī)格: 0.2ml
IFNG Protein Rat 重組大鼠 IFNG / Ierferon Gamma 蛋白 (Fc 標(biāo)簽)
大鼠表皮角質(zhì)形成細(xì)胞完全培養(yǎng)基 100mL
IL18R1 Others Rat 大鼠 IL18R1 人細(xì)胞裂解液 (陽性對(duì)照)
HCT-8 [HRT-18]人回盲細(xì)胞 HCT-8 [HRT-18] human ileocecal carcinoma cells 1640+10% FBS
原代骨細(xì)胞特制基礎(chǔ)無血清培養(yǎng)基Many types of cells包裝:500/100ml
MC3T3-E1 Subclone 14(小鼠顱頂前骨細(xì)胞亞克隆14) 5×106cells/瓶×2 CHO(中國倉鼠卵巢細(xì)胞)
CM-R116大鼠視網(wǎng)膜色素上皮細(xì)胞完全培養(yǎng)基100mL
HA Others H9N2 甲型 H9N2 (A/Chicken/Hong Kong/G9/97) 血凝素HA1 (Hemagglutinin) 人細(xì)胞裂解液 (陽性對(duì)照)
小鼠腎成纖維細(xì)胞完全培養(yǎng)基 100mL
P3/NSI/1-Ag4-1 [NS-1]小鼠細(xì)胞 P3/NSI/1-Ag4-1 mouse myeloma cell line [NS-1] DMEM培養(yǎng)基+10%FBS
IL12A & IL12B Protein Mouse 重組小鼠 IL-12 (IL12A & IL12B Heterodimer) 蛋白
UACC-812(人導(dǎo)管瘤細(xì)胞) 5×106cells/瓶×2 EB-3 [EB3](人淋巴樣Butt細(xì)胞)
組蛋白甲基轉(zhuǎn)移酶SMYD2抗體費(fèi)用 IFNG Protein Rat 重組大鼠 IFNG / Ierferon Gamma 蛋白 (Fc 標(biāo)簽)
大鼠表皮角質(zhì)形成細(xì)胞完全培養(yǎng)基 100mL
IL18R1 Others Rat 大鼠 IL18R1 人細(xì)胞裂解液 (陽性對(duì)照)
HCT-8 [HRT-18]人回盲細(xì)胞 HCT-8 [HRT-18] human ileocecal carcinoma cells 1640+10% FBS
原代骨細(xì)胞特制基礎(chǔ)無血清培養(yǎng)基Many types of cells包裝:500/100ml
MC3T3-E1 Subclone 14(小鼠顱頂前骨細(xì)胞亞克隆14) 5×106cells/瓶×2 CHO(中國倉鼠卵巢細(xì)胞)
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):
1. 組蛋白甲基轉(zhuǎn)移酶SMYD2抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件;
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用;
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定:
1)組蛋白甲基轉(zhuǎn)移酶SMYD2抗體費(fèi)用 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力。抗體的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競爭抑制試驗(yàn)測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。